Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2020 Sep;131(3):876-884.
doi: 10.1213/ANE.0000000000004509.

Effects of Obstructive Sleep Apnea and Obesity on Morphine Pharmacokinetics in Children

Nicholas M Dalesio  1 , Carlton K K Lee  2 , Craig W Hendrix  3 , Nikole Kerns  4 , Aaron Hsu  4 , William Clarke  3 , Joseph M Collaco  5 , Sharon McGrath-Morrow  5 , Myron Yaster  6 , Robert H Brown  4 , Alan R Schwartz  1
Affiliations
Comparative Study

Effects of Obstructive Sleep Apnea and Obesity on Morphine Pharmacokinetics in Children

Nicholas M Dalesio et al. Anesth Analg. 2020 Sep.

Erratum in

Abstract

Background: Obesity increases susceptibility to chronic pain, increases metabolism, and is associated with obstructive sleep apnea syndrome (OSAS), all which can complicate perioperative pain management of patients. In addition, obesity and OSAS can cause elevation of the adipose-derived hormone leptin, which increases metabolism. We hypothesized that obesity along with sleep apnea and leptin independently enhance morphine pharmacokinetics.

Methods: Children 5-12 years of age who were presenting for surgery were administered a morphine dose of 0.05 mg/kg. Blood was collected at baseline and at subsequent preset times for pharmacokinetic analysis of morphine and its metabolites. Three groups were studied: a nonobese group with severe OSAS, an obese group with severe OSAS, and a control group.

Results: Thirty-four patients consisting of controls (n = 16), nonobese/OSAS (n = 8), and obese/OSAS (n = 10) underwent analysis. The obese/OSAS group had a higher dose-adjusted mean maximum morphine concentration (CMAX) over 540 minutes compared to the controls (P < .001) and those with only OSAS (P = .014). The obese/OSAS group also had lower volume of distribution (Vd) when compared to OSAS-only patients (P = .007). In addition, those in the obese/OSAS group had a higher morphine 3-glucuronide (M3G) maximum concentration (P = .012) and a higher ratio of M3G to morphine than did the control group (P = .011). Time to maximum morphine 6-glucuronide (M6G) concentration was significantly lower in both nonobese/OSAS and obese/OSAS groups than in the control group (P < .005). C-reactive protein (CRP), interleukin (IL)-10, and leptin were all higher in the obese/OSAS group than in controls (P = .004, 0.026, and <0.001, respectively), and compared to OSAS-only patients, CRP (P = .013) and leptin (P = .002) levels were higher in the obese/OSAS group.

Conclusions: The combination of obesity and OSAS was associated with an increase in morphine metabolism compared with that in normal-weight controls. Our previous study in mice demonstrated that obesity from leptin deficiency decreased morphine metabolism, but that metabolism normalized after leptin replacement. Leptin may be a cause of the increased morphine metabolism observed in obese patients.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1.
Figure 1.
Comparison of mean serum morphine concentrations measured at preset time points after morphine injection in normal-weight patients without OSAS, patients with severe OSAS only, and obese patients with severe OSAS. OSAS indicates obstructive sleep apnea syndrome.
Figure 2.
Figure 2.
CMAX of MS. Comparison of mean (±SD) CMAX for plasma morphine during 540 minutes of blood sampling time between normal-weight, non-OSAS controls, nonobese OSAS, and obese patients with OSAS. Dose-adjusted mean CMAX in obese patients with OSAS is also presented. *P < .05 versus the nonobese/non-OSAS control group. CMAX indicates maximum concentration; MS, morphine sulfate; OSAS, obstructive sleep apnea syndrome; SD, standard deviation.
Figure 3.
Figure 3.
Comparison of biomarker concentrations between normal-weight and obese patients with and without OSAS. *P < .05 versus nonobese/non-OSAS control group. +P < .05 versus obese/OSAS group. Units of measurement are as follows: CRP (μg/mL), IL-1β (pg/mL), IL-10 (pg/mL), insulin (μU/mL), leptin (ng/mL), TNF-α (pg/mL). Concentrations of IL-1, IL-6, and IL-10 were multiplied by 10 to optimize visual comparisons on the graph. CRP indicates C-reactive protein; IL, interleukin; OSAS, obstructive sleep apnea syndrome; TNF, tumor necrosis factor.
See this image and copyright information in PMC

Comment in

  • Pharmacokinetics Police.
    Fisher DM, Shafer SL. Fisher DM, et al. Anesth Analg. 2022 Feb 1;134(2):e7-e8. doi: 10.1213/ANE.0000000000005813. Anesth Analg. 2022. PMID: 35030129 No abstract available.
  • In Response.
    Dalesio NM, Lee CKK, Hendrix CW. Dalesio NM, et al. Anesth Analg. 2022 Feb 1;134(2):e8-e9. doi: 10.1213/ANE.0000000000005814. Anesth Analg. 2022. PMID: 35030130 No abstract available.

Similar articles

See all similar articles

Cited by

References

    1. Jimenez N, Posner KL, Cheney FW, Caplan RA, Lee LA, Domino KB. An update on pediatric anesthesia liability: a closed claims analysis. Anesth Analg. 2007;104:147–153. - PubMed
    1. Statham MM, Elluru RG, Buncher R, Kalra M. Adenotonsillectomy for obstructive sleep apnea syndrome in young children: prevalence of pulmonary complications. Arch Otolaryngol Head Neck Surg. 2006;132:476–480. - PubMed
    1. Cheng J, Elden L. Outcomes in children under 12 months of age undergoing adenotonsillectomy for sleep-disordered breathing. Laryngoscope. 2013;123:2281–2284. - PubMed
    1. Gleich SJ, Olson MD, Sprung J, et al. Perioperative outcomes of severely obese children undergoing tonsillectomy. Paediatr Anaesth. 2012;22:1171–1178. - PMC - PubMed
    1. Schwengel DA, Sterni LM, Tunkel DE, Heitmiller ES. Perioperative management of children with obstructive sleep apnea. Anesth Analg. 2009;109:60–75. - PubMed

Publication types

MeSH terms

-